231 related articles for article (PubMed ID: 3316049)
21. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
22. Expression of HLA class II determinants by normal and chronic myeloid leukemia progenitors.
Piacibello W; Aglietta M; Stacchini A; Spinelli P; Salvetti L; Kerim S; Malavasi F; Infelise V; Resegotti L; Gavosto F
Leuk Res; 1987; 11(3):285-90. PubMed ID: 3470577
[TBL] [Abstract][Full Text] [Related]
23. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
[TBL] [Abstract][Full Text] [Related]
24. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis.
Haslam PL; Parker DJ; Townsend PJ
Chest; 1990 Mar; 97(3):651-61. PubMed ID: 2306967
[TBL] [Abstract][Full Text] [Related]
25. Gamma-interferon induces differential expression of HLA-DR, -DP and -DQ in human ciliary epithelial cells.
Helbig H; Kittredge KL; Palestine AG; Coca-Prados M; Nussenblatt RB
Graefes Arch Clin Exp Ophthalmol; 1991; 229(2):191-4. PubMed ID: 1904385
[TBL] [Abstract][Full Text] [Related]
26. Expression of HLA-A,B,C, beta 2-microglobulin (beta 2m), HLA-DR, -DP, -DQ and of HLA-D-associated invariant chain (Ii) in soft-tissue tumors.
Mechtersheimer G; Staudter M; Majdic O; Dörken B; Moldenhauer G; Möller P
Int J Cancer; 1990 Nov; 46(5):813-23. PubMed ID: 2228310
[TBL] [Abstract][Full Text] [Related]
27. Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine.
Horie Y; Chiba M; Iizuka M; Masamune O
Gastroenterol Jpn; 1990 Oct; 25(5):575-84. PubMed ID: 2227249
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
[TBL] [Abstract][Full Text] [Related]
29. [Characteristics of cell membrane of B-lymphocytes in chronic lymphocytic leukemia. I. Expression of class II antigens (HLA-D)].
Pluta A; Górski A; Nowaczyk M
Pol Arch Med Wewn; 1991 Sep; 86(3):149-53. PubMed ID: 1725558
[TBL] [Abstract][Full Text] [Related]
30. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens.
Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A
J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061
[TBL] [Abstract][Full Text] [Related]
31. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
32. Immunoelectron localization of HLA-DR, HLA-DP, and HLA-DQ antigens on the microvasculature in normal skin.
Suzumura Y; Ohashi M
J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):202-5. PubMed ID: 8335739
[TBL] [Abstract][Full Text] [Related]
33. [Expression of HLA-DR, DP, DQ antigens in fibrous sino-nasal polyps].
Leprini A; Garaventa G; Leprini AE; Pallestrini E; Pallestrini EA
Boll Soc Ital Biol Sper; 1993 Jun; 69(6):395-401. PubMed ID: 8148117
[TBL] [Abstract][Full Text] [Related]
34. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
Brooks CF; Moore M
Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
[TBL] [Abstract][Full Text] [Related]
35. Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus.
Farthing PM; Cruchley AT
J Oral Pathol Med; 1989 May; 18(5):305-9. PubMed ID: 2475620
[TBL] [Abstract][Full Text] [Related]
36. Stoichiometry of HLA class II-invariant chain oligomers.
Koch N; Zacharias M; König A; Temme S; Neumann J; Springer S
PLoS One; 2011 Feb; 6(2):e17257. PubMed ID: 21364959
[TBL] [Abstract][Full Text] [Related]
37. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
38. The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.
Möller P; Lämmler B; Herrmann B; Otto HF; Moldenhauer G; Momburg F
Immunology; 1986 Nov; 59(3):411-7. PubMed ID: 3491784
[TBL] [Abstract][Full Text] [Related]
39. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.
Ono SJ; Bazil V; Sugawara M; Strominger JL
J Exp Med; 1991 Mar; 173(3):629-37. PubMed ID: 1997650
[TBL] [Abstract][Full Text] [Related]
40. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
